The MYBL2–CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophagesBaoyue Pan, Min Zheng, Xiaojing Zheng et al.|Cancer Cell International|2023Cited by 29
Targeting the Cdc2‐like kinase 2 for overcoming platinum resistance in ovarian cancerYingxin Jiang, Min Zheng, Shuting Huang et al.|MedComm|2024Cited by 9
ACY1-mediated deacetylation of GSTP1 at lysine 30 suppresses cisplatin resistance in epithelial ovarian cancerZheng Min, Wei-Hua Jia, Xiaojing Zheng et al.|Research Square|2022Cited by 0